Global Intravenous (IV) Solutions Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI05241923

Publication Date:

May 20, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

According to our Publisher latest study, the global Intravenous (IV) Solutions market size was valued at US$ 10760 million in 2023. With growing demand in downstream market, the Intravenous (IV) Solutions is forecast to a readjusted size of US$ 15540 million by 2030 with a CAGR of 5.4% during review period.
The research report highlights the growth potential of the global Intravenous (IV) Solutions market. Intravenous (IV) Solutions are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Intravenous (IV) Solutions. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Intravenous (IV) Solutions market.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 77%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
Key Features:
The report on Intravenous (IV) Solutions market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Intravenous (IV) Solutions market. It may include historical data, market segmentation by Type (e.g., Peripheral Parenteral Nutrition, Total Parenteral Nutrition), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Intravenous (IV) Solutions market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Intravenous (IV) Solutions market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Intravenous (IV) Solutions industry. This include advancements in Intravenous (IV) Solutions technology, Intravenous (IV) Solutions new entrants, Intravenous (IV) Solutions new investment, and other innovations that are shaping the future of Intravenous (IV) Solutions.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Intravenous (IV) Solutions market. It includes factors influencing customer ' purchasing decisions, preferences for Intravenous (IV) Solutions product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Intravenous (IV) Solutions market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Intravenous (IV) Solutions market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Intravenous (IV) Solutions market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Intravenous (IV) Solutions industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Intravenous (IV) Solutions market.
Market Segmentation:
Intravenous (IV) Solutions market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segmentation by application
Hospital & Clinics
Ambulatory
Home Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous (IV) Solutions Market Size 2019-2030
2.1.2 Intravenous (IV) Solutions Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Intravenous (IV) Solutions Segment by Type
2.2.1 Peripheral Parenteral Nutrition
2.2.2 Total Parenteral Nutrition
2.3 Intravenous (IV) Solutions Market Size by Type
2.3.1 Intravenous (IV) Solutions Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Intravenous (IV) Solutions Market Size Market Share by Type (2019-2024)
2.4 Intravenous (IV) Solutions Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Ambulatory
2.4.3 Home Care
2.5 Intravenous (IV) Solutions Market Size by Application
2.5.1 Intravenous (IV) Solutions Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Intravenous (IV) Solutions Market Size Market Share by Application (2019-2024)
3 Intravenous (IV) Solutions Market Size by Player
3.1 Intravenous (IV) Solutions Market Size Market Share by Players
3.1.1 Global Intravenous (IV) Solutions Revenue by Players (2019-2024)
3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2019-2024)
3.2 Global Intravenous (IV) Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Intravenous (IV) Solutions by Regions
4.1 Intravenous (IV) Solutions Market Size by Regions (2019-2024)
4.2 Americas Intravenous (IV) Solutions Market Size Growth (2019-2024)
4.3 APAC Intravenous (IV) Solutions Market Size Growth (2019-2024)
4.4 Europe Intravenous (IV) Solutions Market Size Growth (2019-2024)
4.5 Middle East & Africa Intravenous (IV) Solutions Market Size Growth (2019-2024)
5 Americas
5.1 Americas Intravenous (IV) Solutions Market Size by Country (2019-2024)
5.2 Americas Intravenous (IV) Solutions Market Size by Type (2019-2024)
5.3 Americas Intravenous (IV) Solutions Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous (IV) Solutions Market Size by Region (2019-2024)
6.2 APAC Intravenous (IV) Solutions Market Size by Type (2019-2024)
6.3 APAC Intravenous (IV) Solutions Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Intravenous (IV) Solutions by Country (2019-2024)
7.2 Europe Intravenous (IV) Solutions Market Size by Type (2019-2024)
7.3 Europe Intravenous (IV) Solutions Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous (IV) Solutions by Region (2019-2024)
8.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2019-2024)
8.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Intravenous (IV) Solutions Market Forecast
10.1 Global Intravenous (IV) Solutions Forecast by Regions (2025-2030)
10.1.1 Global Intravenous (IV) Solutions Forecast by Regions (2025-2030)
10.1.2 Americas Intravenous (IV) Solutions Forecast
10.1.3 APAC Intravenous (IV) Solutions Forecast
10.1.4 Europe Intravenous (IV) Solutions Forecast
10.1.5 Middle East & Africa Intravenous (IV) Solutions Forecast
10.2 Americas Intravenous (IV) Solutions Forecast by Country (2025-2030)
10.2.1 United States Intravenous (IV) Solutions Market Forecast
10.2.2 Canada Intravenous (IV) Solutions Market Forecast
10.2.3 Mexico Intravenous (IV) Solutions Market Forecast
10.2.4 Brazil Intravenous (IV) Solutions Market Forecast
10.3 APAC Intravenous (IV) Solutions Forecast by Region (2025-2030)
10.3.1 China Intravenous (IV) Solutions Market Forecast
10.3.2 Japan Intravenous (IV) Solutions Market Forecast
10.3.3 Korea Intravenous (IV) Solutions Market Forecast
10.3.4 Southeast Asia Intravenous (IV) Solutions Market Forecast
10.3.5 India Intravenous (IV) Solutions Market Forecast
10.3.6 Australia Intravenous (IV) Solutions Market Forecast
10.4 Europe Intravenous (IV) Solutions Forecast by Country (2025-2030)
10.4.1 Germany Intravenous (IV) Solutions Market Forecast
10.4.2 France Intravenous (IV) Solutions Market Forecast
10.4.3 UK Intravenous (IV) Solutions Market Forecast
10.4.4 Italy Intravenous (IV) Solutions Market Forecast
10.4.5 Russia Intravenous (IV) Solutions Market Forecast
10.5 Middle East & Africa Intravenous (IV) Solutions Forecast by Region (2025-2030)
10.5.1 Egypt Intravenous (IV) Solutions Market Forecast
10.5.2 South Africa Intravenous (IV) Solutions Market Forecast
10.5.3 Israel Intravenous (IV) Solutions Market Forecast
10.5.4 Turkey Intravenous (IV) Solutions Market Forecast
10.5.5 GCC Countries Intravenous (IV) Solutions Market Forecast
10.6 Global Intravenous (IV) Solutions Forecast by Type (2025-2030)
10.7 Global Intravenous (IV) Solutions Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 ICU Medical Inc. (U.S.)
11.1.1 ICU Medical Inc. (U.S.) Company Information
11.1.2 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Offered
11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 ICU Medical Inc. (U.S.) Main Business Overview
11.1.5 ICU Medical Inc. (U.S.) Latest Developments
11.2 B. Braun Melsungen AG (Germany)
11.2.1 B. Braun Melsungen AG (Germany) Company Information
11.2.2 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Offered
11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 B. Braun Melsungen AG (Germany) Main Business Overview
11.2.5 B. Braun Melsungen AG (Germany) Latest Developments
11.3 Fresenius Kabi AG (Germany)
11.3.1 Fresenius Kabi AG (Germany) Company Information
11.3.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Offered
11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Fresenius Kabi AG (Germany) Main Business Overview
11.3.5 Fresenius Kabi AG (Germany) Latest Developments
11.4 Baxter (U.S.)
11.4.1 Baxter (U.S.) Company Information
11.4.2 Baxter (U.S.) Intravenous (IV) Solutions Product Offered
11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Baxter (U.S.) Main Business Overview
11.4.5 Baxter (U.S.) Latest Developments
11.5 Amanta Healthcare (India)
11.5.1 Amanta Healthcare (India) Company Information
11.5.2 Amanta Healthcare (India) Intravenous (IV) Solutions Product Offered
11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Amanta Healthcare (India) Main Business Overview
11.5.5 Amanta Healthcare (India) Latest Developments
11.6 Terumo Medical Corporation (Tokyo)
11.6.1 Terumo Medical Corporation (Tokyo) Company Information
11.6.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Offered
11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Terumo Medical Corporation (Tokyo) Main Business Overview
11.6.5 Terumo Medical Corporation (Tokyo) Latest Developments
11.7 Grifols S.A. (Spain)
11.7.1 Grifols S.A. (Spain) Company Information
11.7.2 Grifols S.A. (Spain) Intravenous (IV) Solutions Product Offered
11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Grifols S.A. (Spain) Main Business Overview
11.7.5 Grifols S.A. (Spain) Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂